|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/04 | (nenurodyta) |
| A61K 31/505 | (nenurodyta) | ||
| A61P 9/08 | (nenurodyta) |
| (11) | Number of the document | 1689751 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04798876.1 |
| Date of filing the European patent application | 2004-11-12 | |
| (97) | Date of publication of the European application | 2006-08-16 |
| (45) | Date of publication and mention of the grant of the patent | 2010-10-20 |
| (46) | Date of publication of the claims translation | 2011-02-25 |
| (86) | Number | PCT/IB2004/003747 |
| Date | 2004-11-12 |
| (87) | Number | WO 2005/049616 |
| Date | 2005-06-02 |
| (30) | Number | Date | Country code |
| 0327319 | 2003-11-24 | GB |
| (72) |
BELL, Andrew Simon, GB
BROWN, David Graham, GB
DACK, Kevin Neil, GB
FOX, David Nathan A., GB
MARSH, Ian Roger, GB
MORRELL, Andrew Ian, GB
PALMER, Michael John, GB
WINSLOW, Carol Ann, GB
|
| (73) |
Pfizer, Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 5,7-Diaminopirazol[4,3-D] pirimidinai su PDE-5 slopinančiu aktyvumu |
| 5,7-DIAMINOPYRAZOLO[4,3-D]PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY |
| Payment date | Validity (years) | Amount | |
| 2017-11-07 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-11-12 |